Hydralazine hydrochloride is a direct-acting arteriolar vasodilator primarily indicated for the treatment of essential hypertension and heart failure, including severe hypertension and pregnancy-induced… Read more





Hydralazine hydrochloride is a direct-acting arteriolar vasodilator primarily indicated for the treatment of essential hypertension and heart failure, including severe hypertension and pregnancy-induced high blood pressure. This category provides comprehensive analytical support for laboratories working with this therapeutic agent, featuring high-quality reference standards of the active pharmaceutical ingredient. Also included are critical degradation products and synthesis by-products, such as 1-chlorophthalazine and 1-phthalazinone, which are essential for rigorous impurity profiling and method validation. By utilizing these pharmacopeial and non-pharmacopeial impurities, as well as stable isotope labelled compounds, analytical chemists can accurately quantify potential contaminants and verify the purity and stability of pharmaceutical formulations. These reference materials facilitate precise quality control throughout the drug development lifecycle, ensuring compliance with regulatory standards for safety and efficacy in hydralazine hydrochloride drug products.